← Leaderboards
Laine J Murphey
Vanderbilt University
$815,695
Attributed
$815,695
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$815,695 · 2
By mechanism
K23$747,955 · 1
M01$67,740 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- Nancy Joan Brown$32,445,188
- Douglas Eugene Vaughan$19,799,621
- John D Imig$12,270,295
- James V Gainer$1,974,030
- Iekuni Ichikawa$3,920,117
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectClinical ResearchBlood ChemistryUrinalysisAngiotensin /Renin /Aldosterone HypertensionPolymerase Chain ReactionRacial /Ethnic DifferenceRadioimmunoassayStatistics /BiometryAfrican AmericanCaucasian AmericanDietary MineralDietary SodiumFamilial HypertensionFlame PhotometryGene Environment InteractionGenetic RegulationLiquid ChromatographyMass SpectrometryBradykininHypertensionOxidative StressAngiotensin ReceptorAngiotensin Ii
Grant awards (7)
ANGIOTENSIN RECEPTOR BLOCKERS AND OXIDATIVE STRESS$56,186
M01 · FY2005 · RR
SYSTEMIC BRADYKININ IN HUMAN HYPERTENSION$149,591
K23 · FY2004 · HL
Angiotensin receptor blockers and oxidative stress$11,554
M01 · FY2004 · RR
SYSTEMIC BRADYKININ IN HUMAN HYPERTENSION$149,591
K23 · FY2003 · HL
SYSTEMIC BRADYKININ IN HUMAN HYPERTENSION$149,591
K23 · FY2002 · HL
SYSTEMIC BRADYKININ IN HUMAN HYPERTENSION$149,591
K23 · FY2001 · HL
SYSTEMIC BRADYKININ IN HUMAN HYPERTENSION$149,591
K23 · FY2000 · HL